Epidemiology


Etiology


  • Pathogen: Bordetella pertussis is a gram‑negative, obligate aerobic coccobacillus.b2a1d48fe8094cb3ed01f68272c4182e.jpg

Pathophysiology


  • Proliferation of Bordetella pertussis on ciliated epithelial cells of the respiratory mucosa → production of virulence factors (e.g., tracheal cytotoxin) → paralysis of respiratory epithelium cilia and inflammation → secretion of inflammatory exudate into respiratory tract → compromise of small airways → cough, pneumonia, cyanosis
  • Bordetella pertussis produces pertussis toxin → ADP-ribosylation of the α subunit of Gi protein → inhibition of Gi protein → adenylate cyclase disinhibition → cAMP accumulation → impaired cell signaling pathways → systemic manifestations associated with whooping cough (e.g., hypoglycemia, lymphocytosis, modulation of host immune response)

Clinical features


  • Catarrhal (1-2 weeks): mild cough, rhinitis
  • Paroxysmal (2-6 weeks): severe coughing spells with inspiratory whoop, posttussive emesis (risk of dehydration); ± apnea/cyanosis (infants)
    • Lungs are usually clear to auscultation
  • Convalescent (weeks to months): gradual resolution

Diagnostics


Treatment


  • First-line: macrolides
    • Preferred: azithromycin